Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma

BACKGROUND: The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. However, the composition of other immune components in CCP and their potential rol...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Open Forum Infect Dis
Päätekijät: Bonny, Tania S, Patel, Eshan U, Zhu, Xianming, Bloch, Evan M, Grabowski, M Kate, Abraham, Alison G, Littlefield, Kirsten, Shrestha, Ruchee, Benner, Sarah E, Laeyendecker, Oliver, Shoham, Shmuel, Sullivan, David, Quinn, Thomas C, Casadevall, Arturo, Pekosz, Andrew, Redd, Andrew D, Tobian, Aaron A R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Major Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717355/
https://ncbi.nlm.nih.gov/pubmed/33553467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa574
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia